Course: Clinical Outcomes for Patients With Anosmia 1 Year After COVID-19 Diagnosis
CME Credits: 1.00
Released: 2021-06-24
Since the pandemic was declared in early 2020, COVID-19–related anosmia quickly emerged as a telltale sign of infection.1,2 However, the time course and reversibility of COVID-19–related olfactory disorders, which may persist and negatively affect patients’ lives, require further study. To clarify the clinical course and prognosis, we followed a cohort of patients with COVID-19–related anosmia for 1 year and performed repeated olfactory function evaluations for a subset of patients.
Educational Objective
To identify the key insights or developments described in this article
View Full Course